At the end of their cycle, hematocrit ranges had increased by 3%-place compared with baseline. The increase wasn't connected to longer use or bigger AAS dose. A cause of this could possibly be that, beyond a particular degree of androgenic activity, no additional increase of hematocrit takes place: a ‘ceiling influence’. Notably, whereas only 5… Read More